Pain Research
Products Related to Pain Research(225)
- GC41181LY2183240 2'-isomerCAS: 1010096-65-7Purity: >98.00%
LY2183240 is a potent, competitive small molecule inhibitor of anandamide uptake (IC50 = 270 pM; Ki = 540 pM) and hydrolysis.
- GC41191(±)13(14)-EpDPACAS: 895127-64-7Purity: >95.00%
Cytochrome P450 metabolism of polyunsaturated fatty acids produces numerous bioactive epoxide regioisomers.
- GC41203(±)7(8)-EpDPACAS: 895127-66-9Purity: >95.00%
Docosahexaenoic acid is the most abundant ω-3 fatty acid in neural tissues, especially in the brain and retina.
- GC41270N-desmethyl ZolmitriptanCAS: 139264-35-0Purity: >95.00%
N-desmethyl Zolmitriptan (DZT) is an active metabolite of the serotonin (5-HT) receptor subtype 5-HT1B and 5-HT1D agonist zolmitriptan.
- GC41499α-PhellandreneCAS: 99-83-2Purity: >80.00%
α-Phellandrene is a cyclic monoterpene that has been found in various plants, including Cannabis, and has diverse biological activities.
- GC41685(±)-WIN 55,212 (mesylate)CAS: 137795-17-6Purity: >98.00%
(±)-WIN 55,212-2 is a potent aminoalkylindole cannabinoid (CB) receptor agonist with a Ki value of 62.3 and 3.3 nM for human recombinant central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors, respectively.
- GC41697(Ala1)-PAR4 (1-6) amide (mouse) (trifluoroacetate salt)Purity: >95.00%
(Ala1)-PAR4 (1-6) amide (mouse) is a peptide agonist of proteinase-activated receptor 4 (PAR4) that induces aggregation of rat and human platelets in vitro (EC50s = 15 and 60 μM, respectively).
- GC422583-Cysteinylacetaminophen (trifluoroacetate salt)CAS: 1331891-93-0Purity: >98.00%
An acetaminophen-protein adduct
- GC424024-hydroxy (S)-Duloxetine β-D-Glucuronide (sodium salt)Purity: >95.00%
4-hydroxy (S)-Duloxetine β-D-glucuronide is an inactive metabolite of the serotonin and norepinephrine reuptake inhibitor (S)-duloxetine.
- GC425505-hydroxy-6-methoxy (S)-DuloxetineCAS: 741693-79-8Purity: >95.00%
5-hydroxy-6-methoxy (S)-Duloxetine is a metabolite of (S)-duloxetine.
- GC425806-hydroxy ChlorzoxazoneCAS: 1750-45-4Purity: >97.00%
6-hydroxy Chlorzoxazone is the primary metabolite of Chlorzoxazone in vivo. 6-hydroxy Chlorzoxazone is mainly formed through the hepatic cytochrome P450 enzyme system and is commonly used as a probe in biochemical research to quantitatively evaluate CYP2E1 activity.
- GC42693Acetaminophen Glucuronide (sodium salt)CAS: 120595-80-4Purity: >98.00%
Acetaminophen glucuronide is an inactive metabolite of the analgesic and antipyretic agent acetaminophen.
- GC42694Acetaminophen sulfate (potassium salt)CAS: 32113-41-0Purity: >98.00%
Acetaminophen sulfate is a metabolite of acetaminophen.
- GC42704Acetyl β-Endorphin (human) (trifluoroacetate salt)Purity: >95.00%
Acetyl β-endorphin is an acetylated derivative of β-endorphin that binds to opioid receptors in rat caudal dorsomedial medulla (Ki = 490 nM) and mouse brain membrane preparations (IC50 = 109 nM).
- GC42809Angiotensin II (3-8) (human, rat, mouse) (trifluoroacetate salt)Purity: >95.00%
Angiotensin II (3-8) is an endogenous C-terminal fragment of the peptide vasoconstrictor angiotensin II.
- GC42934Biocytin-β-Endorphin (human) (trifluoroacetate salt)Purity: >95.00%
Biocytin-β-endorphin is a form of β-endorphin that is conjugated to biocytin.
- GC42990BupivacaineCAS: 38396-39-3Purity: >98.00%
Bupivacaine is a sodium channel blocker and local anesthetic.
- GC43216CCR4 Antagonist (hydrochloride)CAS: 1784252-84-1Purity: >98.00%
CCR4 antagonist is an antagonist of CC chemokine receptor 4 (CCR4) that inhibits human CCL22-derived [35S]GTPγS and [125I]CCL22 binding in vitro (IC50s = 19 and 70 nM, respectively).
- GC43327CTAP (trifluoroacetate salt)Purity: >98.00%
CTAP is a water soluble, cyclic octapeptide which acts as a receptor antagonist that is selective for the μ opioid receptor (IC50 = 3.5 nM) over the δ receptor (IC50 = 4,500 nM).
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC41181 | LY2183240 2'-isomer | 1010096-65-7 | >98.00% | |
LY2183240 is a potent, competitive small molecule inhibitor of anandamide uptake (IC50 = 270 pM; Ki = 540 pM) and hydrolysis. | ||||
| GC41191 | (±)13(14)-EpDPA | 895127-64-7 | >95.00% | |
Cytochrome P450 metabolism of polyunsaturated fatty acids produces numerous bioactive epoxide regioisomers. | ||||
| GC41203 | (±)7(8)-EpDPA | 895127-66-9 | >95.00% | |
Docosahexaenoic acid is the most abundant ω-3 fatty acid in neural tissues, especially in the brain and retina. | ||||
| GC41270 | N-desmethyl Zolmitriptan | 139264-35-0 | >95.00% | |
N-desmethyl Zolmitriptan (DZT) is an active metabolite of the serotonin (5-HT) receptor subtype 5-HT1B and 5-HT1D agonist zolmitriptan. | ||||
| GC41499 | α-Phellandrene | 99-83-2 | >80.00% | |
α-Phellandrene is a cyclic monoterpene that has been found in various plants, including Cannabis, and has diverse biological activities. | ||||
| GC41599 | URB754 | 86672-58-4 | >98.00% | |
URB754 is a potent and noncompetitive inhibitor of monoacylglycerol lipase (MAGL), exhibiting an IC50 value of 200 nM for the recombinant rat brain enzyme. | ||||
| GC41685 | (±)-WIN 55,212 (mesylate) | 137795-17-6 | >98.00% | |
(±)-WIN 55,212-2 is a potent aminoalkylindole cannabinoid (CB) receptor agonist with a Ki value of 62.3 and 3.3 nM for human recombinant central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors, respectively. | ||||
| GC41697 | (Ala1)-PAR4 (1-6) amide (mouse) (trifluoroacetate salt) | - | >95.00% | |
(Ala1)-PAR4 (1-6) amide (mouse) is a peptide agonist of proteinase-activated receptor 4 (PAR4) that induces aggregation of rat and human platelets in vitro (EC50s = 15 and 60 μM, respectively). | ||||
| GC42258 | 3-Cysteinylacetaminophen (trifluoroacetate salt) | 1331891-93-0 | >98.00% | |
An acetaminophen-protein adduct | ||||
| GC42402 | 4-hydroxy (S)-Duloxetine β-D-Glucuronide (sodium salt) | - | >95.00% | |
4-hydroxy (S)-Duloxetine β-D-glucuronide is an inactive metabolite of the serotonin and norepinephrine reuptake inhibitor (S)-duloxetine. | ||||
| GC42550 | 5-hydroxy-6-methoxy (S)-Duloxetine | 741693-79-8 | >95.00% | |
5-hydroxy-6-methoxy (S)-Duloxetine is a metabolite of (S)-duloxetine. | ||||
| GC42580 | 6-hydroxy Chlorzoxazone | 1750-45-4 | >97.00% | |
6-hydroxy Chlorzoxazone is the primary metabolite of Chlorzoxazone in vivo. 6-hydroxy Chlorzoxazone is mainly formed through the hepatic cytochrome P450 enzyme system and is commonly used as a probe in biochemical research to quantitatively evaluate CYP2E1 activity. | ||||
| GC42693 | Acetaminophen Glucuronide (sodium salt) | 120595-80-4 | >98.00% | |
Acetaminophen glucuronide is an inactive metabolite of the analgesic and antipyretic agent acetaminophen. | ||||
| GC42694 | Acetaminophen sulfate (potassium salt) | 32113-41-0 | >98.00% | |
Acetaminophen sulfate is a metabolite of acetaminophen. | ||||
| GC42704 | Acetyl β-Endorphin (human) (trifluoroacetate salt) | - | >95.00% | |
Acetyl β-endorphin is an acetylated derivative of β-endorphin that binds to opioid receptors in rat caudal dorsomedial medulla (Ki = 490 nM) and mouse brain membrane preparations (IC50 = 109 nM). | ||||
| GC42809 | Angiotensin II (3-8) (human, rat, mouse) (trifluoroacetate salt) | - | >95.00% | |
Angiotensin II (3-8) is an endogenous C-terminal fragment of the peptide vasoconstrictor angiotensin II. | ||||
| GC42865 | AT-121 | 2099681-31-7 | >95.00% | |
AT-121 is a dual μ-opioid and nociceptin receptor partial agonist (Kis = 16.49 and 3.67 nM, respectively). | ||||
| GC42885 | AX 048 | 873079-69-7 | >98.00% | |
The group IVA phospholipase A2 (PLA2), known as calcium-dependent cytosolic PLA2 (cPLA2), selectively releases arachidonic acid from membrane phospholipids, playing a central role in initiating the synthesis of prostaglandins and leukotrienes. | ||||
| GC42934 | Biocytin-β-Endorphin (human) (trifluoroacetate salt) | - | >95.00% | |
Biocytin-β-endorphin is a form of β-endorphin that is conjugated to biocytin. | ||||
| GC42990 | Bupivacaine | 38396-39-3 | >98.00% | |
Bupivacaine is a sodium channel blocker and local anesthetic. | ||||
| GC43155 | CAY10448 | 1177195-52-6 | >98.00% | |
Capsaicin is the primary active component of the heat and pain-eliciting lipid soluble fraction of the Capsicum pepper. | ||||
| GC43171 | CAY10568 | 22913-17-3 | >98.00% | |
Most local anesthetics act by abolishing voltage gated sodium channel currents indiscriminately in all populations of neurons. | ||||
| GC43216 | CCR4 Antagonist (hydrochloride) | 1784252-84-1 | >98.00% | |
CCR4 antagonist is an antagonist of CC chemokine receptor 4 (CCR4) that inhibits human CCL22-derived [35S]GTPγS and [125I]CCL22 binding in vitro (IC50s = 19 and 70 nM, respectively). | ||||
| GC43327 | CTAP (trifluoroacetate salt) | - | >98.00% | |
CTAP is a water soluble, cyclic octapeptide which acts as a receptor antagonist that is selective for the μ opioid receptor (IC50 = 3.5 nM) over the δ receptor (IC50 = 4,500 nM). | ||||
